R. Gold Et Al. , "Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS," 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , vol.14, Montreal, Canada, 2008
Gold, R. Et Al. 2008. Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS. 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , (Montreal, Canada).
Gold, R., Kappos, L., Miller, D. H., Havrdova, E., Limmroth, V., Polman, C., ... ERAKSOY, M.(2008). Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS . 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Canada
Gold, Ralf Et Al. "Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS," 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Canada, 2008
Gold, Ralf Et Al. "Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS." 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , Montreal, Canada, 2008
Gold, R. Et Al. (2008) . "Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS." 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis , Montreal, Canada.
@conferencepaper{conferencepaper, author={Ralf Gold Et Al. }, title={Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS}, congress name={13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis}, city={Montreal}, country={Canada}, year={2008}}